Clinical Trial Update: Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating nicardipine to prevent spasm during trans-radial percutaneous coronary intervention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasm Artery

Drugs mentioned

• Nicardipine (nicardipine)

Snippet

Sponsor: Pr. Semir Nouira | Conditions: Spasm Artery | Phase 3 | Status: COMPLETED